They also recently reported that GM-CSF-deficient tumor cells did not show retarded growth rates and had no effect on overall CCL2 expression levels in 4T1 tumor tissue, indicating that non-myeloid-cell-derived CCL2 is also influenced by GM-CSF deletion (21). Here, CCL2 is linked to neoplasm.